Microcrystalline cellulose is a partially depolymerized cellulose produced by treating alpha cellulose, obtained as a pulp from bleached plant fiber, with mineral acids. It is used as a diluent, binder, filling agent and disintegrant in pharmaceutical products. Microcrystalline cellulose has several advantages over other excipients due to its high purity, stability, low cost, its ability to act as lubricant and glidant. The pharmaceutical industry accounts for the major share of the microcrystalline cellulose market owing to its widespread use as an excipient in tablet formulations. Demand from nutraceuticals and food industries are also contributing to the growth of the market.
The Global Microcrystalline Cellulose Market is estimated to be valued at US$ 1349.84 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Microcrystalline Cellulose are Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Genomics, QIAGEN, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio, Zymo Research Corporation, Oxford Nanopore Technologies plc, Tecan Trading AG, Hamilton Company, ZS Genetics, Inc. LI-COR, Inc. These players are focusing on new product launches and partnerships to expand their global presence.
The increasing demand for generic drugs and new drug development presents significant opportunities for microcrystalline cellulose suppliers. Rise in contract manufacturing and laboratories outsourcing also provides growth opportunities.
North America and Europe dominate the global microcrystalline cellulose market, however Asia Pacific is expected to witness highest growth owing to the expanding pharmaceutical industry in the region. Key players are expanding their manufacturing facilities in Asia Pacific to tap the growth potential.
Market drivers: Rising prevalence of chronic diseases worldwide is driving the demand for pharmaceutical drugs, thus propelling the growth of microcrystalline cellulose market. Rapid urbanization and growing health awareness in developing nations are also supporting the market growth.
Market restrain: Strict regulatory norms associated with pharmaceutical excipients may hamper the market growth to some extent.
Segment Analysis
The microcrystalline cellulose market is segmented based on product type, source, application, and region. Within product types, the standard-MCC segment dominated in 2024, accounting for over 55% market share. Standard-MCC is widely used in various industries like food & beverage, pharmaceutical, and personal care owing to its excellent thickening and gelling properties. Within sources, wood-based MCC segment dominated in 2024 due to abundant availability of raw materials like pulp wood and sawmill residues for commercial production.
Global Analysis
Regionally, North America dominated the microcrystalline cellulose market in 2024 with over 35% share owing to strong presence of key players and robust demand from end-use industries like processed food. Asia Pacific is the fastest growing regional market projected to exceed USD 500 Bn by 2031 owing to rapid industrialization, population growth, and rising health awareness in countries like China and India. Within Asia Pacific, China is expected to dominate during the forecast period supported by increasing food processing and pharmaceutical industries along with strong government support for native and international businesses.
Get More Insights On, Microcrystalline Cellulose Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Comments
0 comment